About Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome
Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome is a rare disease catalogued by Orphanet (ORPHA:404437). It is associated with the QARS1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome trials.
Search ClinicalTrials.gov for "Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome" or filter by Orphanet code ORPHA:404437 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome. Updated daily.